MST1R and cancer: SRSF1 controls alternative splicing of the proto-oncogene MST1R (also known as Ron) [125], whose active isoform accumulates in different cancer types and translates into a tyrosine kinase receptor that increases cell mobility, invasion, and resistance to apoptosis-induced death [125,128,129,130,131,132].